Inventor
Ulrik Nielsen
Inventor
Quincy, MA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides23%
B82YSpecific uses or applications of nanostructures8%
C12NMicroorganisms or enzymes8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
PatentTitleYear
10,988,547Bi-specific fusion proteins202110,858,450Bi-specific fusion proteins202010,407,512Bi-specific fusion proteins201910,072,299Antibodies against epidermal growth factor receptor (EGFR) and uses thereof20189,982,060Bi-specific fusion proteins20189,902,999'Antibodies against epidermal growth factor receptor (EGFR) and uses thereof'20189,885,087'Antibodies against epidermal growth factor receptor (EGFR) and uses thereof'20189,718,892'Method of treating myocardial infarction by administering a bi-specific fusion protein'20179,487,588'Antibodies against the ectodomain of ERBB3 and uses thereof'20169,238,080'Bi-specific fusion proteins'20169,226,964'Antibodies against epidermal growth factor receptor (EGFR) and uses thereof'20169,044,460'Antibodies against epidermal growth factor receptor (EGFR) and uses thereof'20158,961,966'Antibodies against ERBB3 and uses thereof'20158,691,231'Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies'20148,691,771'Bi-specific fusion proteins for tissue repair'20148,691,225'Antibodies against the ectodomain of ErbB3 and uses thereof'20148,623,592'Methods and systems for predicting response of cells to a therapeutic agent'20148,440,192'Bispecific binding agents for modulating biological activity'20138,124,085'Bispecific binding agents for modulating biological activity'20127,846,440'Antibodies against ErbB3 and uses thereof'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2018Patents assigned to MERRIMACK PHARMACEUTICALS INC (17)· patent assignee history
2010–2021Based in Quincy, MA, US· patent location history
2014–2016Patents assigned to NIELSEN ULRIK (7)· patent assignee history
2014–2016Patents assigned to SCHOEBERL BIRGIT (5)· patent assignee history
2014–2015Patents assigned to FELDHAUS MICHAEL (3)· patent assignee history
2014–2016Patents assigned to HARMS BRIAN (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERRIMACK PHARMACEUTICALS INC | 17 | 2010–2018 |
| NIELSEN ULRIKself | 7 | 2014–2016 |
| SCHOEBERL BIRGIT | 5 | 2014–2016 |
| FELDHAUS MICHAEL | 3 | 2014–2015 |
| HARMS BRIAN | 3 | 2014–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Quincy, Massachusetts, US | 20 | 2010–2021 |